(Q22241696)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

3

Bob Woods

Bob

Woods

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

7

Martin Orrell

Martin

Orrell

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Aimee Spector

1

Aimee

Spector

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lene Thorgrimsen

2

Lene

Thorgrimsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Lindsay Royan

4

Lindsay

Royan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Steve Davies

5

Steve

Davies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Margaret Butterworth

6

Margaret

Butterworth

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Psychiatry

7 November 2019

published in

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

0 references

page(s)

248-254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Cornell Scale for Depression in Dementia

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

1 reference

7 January 2021

The development of a valid and reliable scale for rating anxiety in dementia (RAID)

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Memory training for severe memory loss: effects on senile dementia patients and their families.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Reality orientation for dementia: a systematic review of the evidence of effectiveness from randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer's Disease (QoL-AD) scale.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Statistics notes: Analysing controlled trials with baseline and follow up measurements

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

A new rating scale for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Reality Orientation, a Therapy for Psychogeriatric Patients: a Controlled Study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Reality Orientation and Staff Attention: a Controlled Study

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Reality orientation and reminiscence therapy. A controlled cross-over study of elderly confused people

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1192%2FBJP.183.3.248

7 January 2021

Identifiers

DOI

10.1192/BJP.183.3.248

2 references

Consolidated OpenCitations Corpus – April 2017

174679

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12948999%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

174679

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

174679